Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasotraline in children with ADHD
NCT02428088Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Apr 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dasotraline in attention deficit hyperactivity disorder (ADHD), sponsored by Sumitomo Pharma America. Started Apr 2015; status: completed.
02
Drugs
dasotraline
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02428088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428088.